Teva Pharmaceutical Industries Limited Announces Pricing Of $1.5 Billion Of Senior Notes

JERUSALEM--(BUSINESS WIRE)--Jan. 27, 2006--Teva Pharmaceutical Industries Limited (Nasdaq: TEVA) announced today that it priced the offering, by its special purpose finance subsidiary, of $500 million of 5.550% senior notes maturing in 2016 and $1 billion of 6.150% senior notes maturing in 2036. These notes will be guaranteed by Teva.

MORE ON THIS TOPIC